Terapi Intravenous Immunoglobulin (IVIG) pada Pasien Covid-19 di Intensive Care Unit (ICU)
Abstract
Keywords
Full Text:
PDFReferences
Wiersinga WD, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (covid-19): a review. J Am Med Assoc 2020; 324(8):782–793.
Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian J. Pediatr 2020; 87(4): 281–286.
Satgas penanganan COVID-1. Peta sebaran COVID-19. 2020. Tersedia pada: https://covid19.go.id/peta- sebaran.
Xie Y, Cao S, Wang R. Effect of regular intravenous immunoglobulin therapy on prognosis of sever pneumonia in patients with COVID-19. J Infect 2020;81(2):318–356.
Nguyen AAA, Habiballah SB, Platt CD, Geha RS, Chou JS, Mcdonald DR. Immunoglobulins in the treatment of COVID-19 infection: proceed with caution. Clin Immunol 2020;216:1-4.
Lanza M et al. Successful intravenous immunoglobulin treatment in severe COVID-19 pneumonia. IDCases 2020; 21:e00794.
Tzilas V, Manali E, Papiris S, Bouros D. Intravenous immunoglobulin for the treatment of COVID-19 : a promising tool. Respiration 2020; 99:1087–1089.
Cao W et al. High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with coronavirus disease 2019. Open Forum Infect Dis 2020;7(3):1–6.
Tabarsi P et al. Evaluating the effects of intravenous immunoglobulin (IVIG) on the management of severe COVID-19 cases: a randomized controlled trial. Int Immunopharmacol 2020;9:107205.
Refbacks
- There are currently no refbacks.